Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer of the PROSTATE”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT03361735
What this trial is testing

Radium Ra 223 Dichloride, Hormone Therapy and Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Adenocarcinoma
City of Hope Medical Center 25
Not applicableWithdrawnNCT03935308
What this trial is testing

Phase I Study MR-guided SBRT to PCa

Who this might be right for
Low or Intermediate Risk Prostate Cancer
Henry Ford Health System
Testing effectiveness (Phase 2)Study completedNCT00928174
What this trial is testing

Measurement of Anti-Androgen Response Using Fluorine-18 Fluorocholine PET/CT in Androgen-Insensitive Prostate Cancer

Who this might be right for
Prostate Cancer
Queen's Medical Center 27
Not applicableLooking for participantsNCT07014618
What this trial is testing

Navigator-Assisted Hypofractionation (NAVAH) on Radiation Therapy Completion in Breast Cancer and Prostate Cancer

Who this might be right for
Breast CancerProstate Cancer
University of Oklahoma 420
Testing effectiveness (Phase 2)Study completedNCT00498797
What this trial is testing

E3-Hormone Refractory Prostrate Cancer Taxotere Combination

Who this might be right for
Prostate CancerMetastaticHormone Refractory
Sanofi 86
Not applicableStudy completedNCT03223597
What this trial is testing

Registry of Treatment Outcomes of Symptomatic Metastasized Castration Resistant Prostate Cancer Treated With Radium-223

Who this might be right for
Prostate Cancer MetastaticBone Metastases
The Netherlands Cancer Institute 300
Not applicableStudy completedNCT05146297
What this trial is testing

Diversity and Inclusion in Research Underpinning Prevention and Therapy Trials

Who this might be right for
Breast CancerLiver CancerProstate Cancer
Icahn School of Medicine at Mount Sinai 585
Early research (Phase 1)UnknownNCT05836623
What this trial is testing

A Phase I Study to Assess PSMA+ and PSMA- Tumour Lesions

Who this might be right for
Advanced and/or Metastatic Solid Tumours
Crescendo Biologics Ltd. 5
Early research (Phase 1)Study completedNCT03218826
What this trial is testing

PI3Kbeta Inhibitor AZD8186 and Docetaxel in Treating Patients Advanced Solid Tumors With PTEN or PIK3CB Mutations That Are Metastatic or Cannot Be Removed by Surgery

Who this might be right for
Advanced Breast CarcinomaAdvanced Malignant Solid NeoplasmAdvanced Prostate Carcinoma+23 more
National Cancer Institute (NCI) 23
Testing effectiveness (Phase 2)Active Not RecruitingNCT03047135
What this trial is testing

Olaparib in Men With High-Risk Biochemically-Recurrent Prostate Cancer Following Radical Prostatectomy, With Integrated Biomarker Analysis

Who this might be right for
Prostate
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 51
Testing effectiveness (Phase 2)Looking for participantsNCT03424850
What this trial is testing

Safety and Efficacy of 21 Gy, 23 Gy and 25 Gy for High Dose Rate (HDR) Prostate Brachytherapy

Who this might be right for
Prostate CancerProstate Neoplasm
Washington University School of Medicine 36
Testing effectiveness (Phase 2)Study completedNCT00054574
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Jonsson Comprehensive Cancer Center
Large-scale testing (Phase 3)Active Not RecruitingNCT04134260
What this trial is testing

Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer, INNOVATE Trial

Who this might be right for
Prostate AdenocarcinomaStage I Prostate Cancer AJCC v8Stage II Prostate Cancer AJCC v8+2 more
NRG Oncology 586
Testing effectiveness (Phase 2)Study completedNCT01284920
What this trial is testing

MDV3100 to Evaluate Safety, Tolerability, Pharmacokinetics and Efficacy of in Prostate Cancer Patients

Who this might be right for
Prostate CancerProstate NeoplasmsCastration Resistant Prostate Cancer (CRPC)
Astellas Pharma Inc 47
Not applicableLooking for participantsNCT06259279
What this trial is testing

High Impact Training to Patients with Prostate Cancer and Bone Metastases

Who this might be right for
Prostate Cancer
Copenhagen University Hospital at Herlev 102
Not applicableNot Yet RecruitingNCT06966089
What this trial is testing

ExosomeDx in MRI-negative Men With High PSA

Who this might be right for
Prostate Cancer
Icahn School of Medicine at Mount Sinai 425
Testing effectiveness (Phase 2)Looking for participantsNCT05413850
What this trial is testing

Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection

Who this might be right for
Prostate CancerMetastatic Castration-resistant Prostate CancermCRPC+3 more
Blue Earth Therapeutics Ltd 82
Large-scale testing (Phase 3)Study completedNCT00002874
What this trial is testing

Radiation Therapy With or Without Bicalutamide for Recurrent pT3N0 Prostate Cancer After Radical Prostatectomy

Who this might be right for
Prostate Cancer
Radiation Therapy Oncology Group 840
Large-scale testing (Phase 3)Study completedNCT07413120
What this trial is testing

Efficacy and Safety of VasoClip® vs. WeckClip® for Robotic Urologic Surgery

Who this might be right for
Prostate Cancer (Adenocarcinoma)Kidney CancersUrothelial Cancer
Incheon St.Mary's Hospital 40
Testing effectiveness (Phase 2)Study completedNCT02614859
What this trial is testing

Bicalutamide With or Without Metformin for Biochemical Recurrence in Overweight or Obese Prostate Cancer Patients

Who this might be right for
Cancer of Prostate
Fox Chase Cancer Center 29
Next Page